Skip to main content
Top
Published in: Diabetologia 12/2006

01-12-2006 | Article

Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight – potential link to increased risk of diabetes?

Authors: S. E. Ozanne, C. B. Jensen, K. J. Tingey, M. S. Martin-Gronert, L. Grunnet, C. Brons, H. Storgaard, A. A. Vaag

Published in: Diabetologia | Issue 12/2006

Login to get access

Abstract

Aims/hypothesis

Individuals with low birthweight are at increased risk of type 2 diabetes mellitus. However, the underlying molecular mechanisms are unknown. Previously we have shown that low birthweight is associated with changes in muscle insulin signalling proteins. Here we determined whether low birthweight is associated with changes in insulin signalling proteins in adipose tissue.

Methods

Men (age 23 years) with either a low (bottom 10th percentile) (n = 17) or a normal (50th–90th percentile) (n = 17) birthweight were recruited from the Danish Medical Birth Registry and subcutaneous adipose biopsies were taken.

Results

Between the two groups there was no difference in protein level of the insulin receptor, protein kinase C zeta, glycogen synthase kinase-3 (GSK3) alpha, GSK3 beta, protein kinase B alpha and beta, peroxisome proliferative activated receptor gamma coactivator 1 or Src-homology-2-containing protein. However, the levels of GLUT4 (also known as solute carrier family 2 [facilitated glucose transporter], member 4 [SLC2A4]) (52 ± 10.9% reduction, p < 0.01), p85α subunit of phosphoinositide 3-kinase (PI3K) (45 ± 9% reduction, p < 0.01), p110ß subunit of PI3K (48 ± 17% reduction, p = 0.06) and IRS1 (59 ± 24% reduction, p < 0.05) were reduced in men of low birthweight.

Conclusions/interpretation

These findings show that low birthweight is associated with reduced levels of adipose insulin signalling proteins, thus providing a potential molecular framework to explain why people with low birthweight are at increased risk of developing type 2 diabetes. These differences precede the development of diabetes and thus may help predict disease risk.
Literature
2.
go back to reference Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birthweight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446PubMedCrossRef Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birthweight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446PubMedCrossRef
3.
go back to reference Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birthweight and genetic abnormalities in twins with increased susceptibility to type 2 diabetes mellitus. Diabet Med 17:365–370PubMedCrossRef Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birthweight and genetic abnormalities in twins with increased susceptibility to type 2 diabetes mellitus. Diabet Med 17:365–370PubMedCrossRef
4.
go back to reference Iliadou A, Cnattingius S, Lichtenstein P (2004) Low birthweight and type 2 diabetes: a study on 11162 Swedish twins. Int J Epidemiol 33:953–954CrossRef Iliadou A, Cnattingius S, Lichtenstein P (2004) Low birthweight and type 2 diabetes: a study on 11162 Swedish twins. Int J Epidemiol 33:953–954CrossRef
5.
go back to reference Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177PubMedCrossRef Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177PubMedCrossRef
6.
go back to reference Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552PubMedCrossRef Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552PubMedCrossRef
7.
go back to reference Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789PubMedCrossRef Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789PubMedCrossRef
8.
go back to reference Graham TE, Yang Q, Bluher M et al (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Eng J Med 354:2552–2563CrossRef Graham TE, Yang Q, Bluher M et al (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Eng J Med 354:2552–2563CrossRef
9.
go back to reference Rajala MW, Scherer PE (2003) Mini review: the adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef Rajala MW, Scherer PE (2003) Mini review: the adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef
10.
go back to reference Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (1993) Adipose tissue hyperplasia and enhanced glucose disposal in transgenic mice over-expressing GLUT 4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (1993) Adipose tissue hyperplasia and enhanced glucose disposal in transgenic mice over-expressing GLUT 4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed
11.
go back to reference Abel ED, Peroni O, Kim JK et al (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729–733PubMedCrossRef Abel ED, Peroni O, Kim JK et al (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729–733PubMedCrossRef
12.
go back to reference Rasmussen EL, Malis C, Jensen CB et al (2005) Altered fat distribution in young adult men who had low birthweight. Diabetes Care 28(1):151–153PubMed Rasmussen EL, Malis C, Jensen CB et al (2005) Altered fat distribution in young adult men who had low birthweight. Diabetes Care 28(1):151–153PubMed
13.
go back to reference McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birthweight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype or surviving small baby genotype? Br Med J 308:942–945 McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birthweight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype or surviving small baby genotype? Br Med J 308:942–945
14.
go back to reference Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year old Caucasian men who had low birthweight. Diabetes 51:1271–1280PubMed Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year old Caucasian men who had low birthweight. Diabetes 51:1271–1280PubMed
15.
go back to reference Schou JH, Pilgaard K, Vilsboll T et al (2005) Normal secretion and action of the gut incretin-like peptide-1 and glucose dependent insulinotropic polypeptide in young men with low birthweight. J Clin Endocrinol Metab 90:4912–4919PubMedCrossRef Schou JH, Pilgaard K, Vilsboll T et al (2005) Normal secretion and action of the gut incretin-like peptide-1 and glucose dependent insulinotropic polypeptide in young men with low birthweight. J Clin Endocrinol Metab 90:4912–4919PubMedCrossRef
17.
go back to reference Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 423:226–230CrossRef Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 423:226–230CrossRef
18.
go back to reference Esau C, Kang X, Peralta E et al (2004) Micro RNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361–52365PubMedCrossRef Esau C, Kang X, Peralta E et al (2004) Micro RNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361–52365PubMedCrossRef
19.
go back to reference Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action — implications for insulin resistance and diabetes mellitus. N Eng J Med 341:248–257CrossRef Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action — implications for insulin resistance and diabetes mellitus. N Eng J Med 341:248–257CrossRef
20.
go back to reference Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1997) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 94:4171–4175PubMedCrossRef Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1997) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 94:4171–4175PubMedCrossRef
21.
go back to reference Smith U, Axelson M, Carvalho E, Eliasson B, Jansson PA, Wesslau C (1999) Insulin signalling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 892:119–126PubMedCrossRef Smith U, Axelson M, Carvalho E, Eliasson B, Jansson PA, Wesslau C (1999) Insulin signalling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 892:119–126PubMedCrossRef
22.
go back to reference Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51 Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51
23.
go back to reference Rondinone CM, Carvalho E, Wesslau C, Smith UP (1999) Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid in adipocytes from subjects with type 2 diabetes mellitus. Diabetologia 42:819–825PubMedCrossRef Rondinone CM, Carvalho E, Wesslau C, Smith UP (1999) Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid in adipocytes from subjects with type 2 diabetes mellitus. Diabetologia 42:819–825PubMedCrossRef
24.
go back to reference Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257PubMedCrossRef Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257PubMedCrossRef
25.
go back to reference Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ (1992) Early growth and abdominal fatness in adult life. J Epidemiol Community Health 46:184–186PubMedCrossRef Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ (1992) Early growth and abdominal fatness in adult life. J Epidemiol Community Health 46:184–186PubMedCrossRef
26.
go back to reference Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019–1022CrossRef Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019–1022CrossRef
Metadata
Title
Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight – potential link to increased risk of diabetes?
Authors
S. E. Ozanne
C. B. Jensen
K. J. Tingey
M. S. Martin-Gronert
L. Grunnet
C. Brons
H. Storgaard
A. A. Vaag
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0466-2

Other articles of this Issue 12/2006

Diabetologia 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine